Amazon-One Medical Deal: Scrutiny Likely, Lawsuit Not
A prevailing antagonism against big companies generally and the power of online platforms specifically may spur antitrust scrutiny of Amazon's $3.9 billion bid for One Medical, but enforcers are unlikely to...To view the full article, register now.
Already a subscriber? Click here to view full article